Marinomed Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Oct 18, 2019

Publication Date: 18.10.2019 17:00 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Name: Erste Asset Management GmbH City: Wien Country: Österreich 4. Name of shareholder(s): Erste Asset Management GmbH 5. Date on which the threshold was crossed or reached: 18.10.2019 6. Total positions

	____________
	% of voting	% of voting
	rights attached rights through Total of both Total number of
	to shares (7.A) financial/other in % (7.A +			voting rights
		instruments	7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on
which threshold	7.71 %	0.00 %	7.71 %	1 469 772
was crossed /
reached
__ __ __ __ __
Position of
previous
notification	0.00 %	0.00 %	0.00 %
(if applicable)
__ __ __ __ __

Details

1. Notified details of the resulting situation:

___________ A: Voting rights attached to shares ___________
		Number of voting rights	% of voting rights ____ _____
	Direct	Indirect	Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
	2018)	2018)	2018)	2018) ___ ___ ___ ___ __
ATMARINOMED6	113 317		7.71 %	___ ___ ___ ___ __
SUBTOTAL A		113 317		7.71 % ___ _____ ________

	____________
	Number of voting
	rights that may
	be
Type of	Expiration Date Exercise Period acquired if the % of voting
instrument	instrument is rights
	exercised
	___ ___ ___ ___ __
	SUBTOTAL B.1
	___ ___ ___ ___ __

2018	___________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG
Type of instrument	___________ Expiration Exercise Date	Period	Physical / Cash	Number of voting rights		% of voting rights
	__ _ ___________ Settlement__ ____ __ _ __ _ ___ __ ___		SUBTOTAL B.2

1. Information in relation to the person subject to the notification obligation: Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

2. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights.

3. Additional comments: The voting rights held by Erste Asset Management GmbH as stated in section 8 are not held directly but by the investment funds managed by the management company. They are therefore not holdings of the management company.

Note of the Issuer: This is a translation of the received shareholder notification in German language. The translation into English is not binding.

Further inquiry note:

Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com

Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at

end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service